| Product Code: ETC7903767 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Latvia saw a significant increase in import shipments of adeno-associated virus vector manufacturing, with top exporting countries including Metropolitan France, Germany, Lithuania, Poland, and the USA. The high Herfindahl-Hirschman Index (HHI) indicates a concentrated market, with a strong Compound Annual Growth Rate (CAGR) of 43.42% from 2020-24. However, the negative growth rate of -57.01% in 2023-24 suggests a potential slowdown in the industry. Overall, Latvia`s reliance on these key exporting countries highlights the importance of strategic partnerships in the adeno-associated virus vector manufacturing sector.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Adeno Associated Virus Vector Manufacturing Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Adeno Associated Virus Vector Manufacturing Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Adeno Associated Virus Vector Manufacturing Market - Industry Life Cycle |
3.4 Latvia Adeno Associated Virus Vector Manufacturing Market - Porter's Five Forces |
3.5 Latvia Adeno Associated Virus Vector Manufacturing Market Revenues & Volume Share, By Scale of Operations, 2021 & 2031F |
3.6 Latvia Adeno Associated Virus Vector Manufacturing Market Revenues & Volume Share, By Therapeutic Area Scope, 2021 & 2031F |
3.7 Latvia Adeno Associated Virus Vector Manufacturing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Latvia Adeno Associated Virus Vector Manufacturing Market Revenues & Volume Share, By Method Scope, 2021 & 2031F |
4 Latvia Adeno Associated Virus Vector Manufacturing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Latvia Adeno Associated Virus Vector Manufacturing Market Trends |
6 Latvia Adeno Associated Virus Vector Manufacturing Market, By Types |
6.1 Latvia Adeno Associated Virus Vector Manufacturing Market, By Scale of Operations |
6.1.1 Overview and Analysis |
6.1.2 Latvia Adeno Associated Virus Vector Manufacturing Market Revenues & Volume, By Scale of Operations, 2021- 2031F |
6.1.3 Latvia Adeno Associated Virus Vector Manufacturing Market Revenues & Volume, By Clinical, 2021- 2031F |
6.1.4 Latvia Adeno Associated Virus Vector Manufacturing Market Revenues & Volume, By Preclinical, 2021- 2031F |
6.1.5 Latvia Adeno Associated Virus Vector Manufacturing Market Revenues & Volume, By Commercial, 2021- 2031F |
6.2 Latvia Adeno Associated Virus Vector Manufacturing Market, By Therapeutic Area Scope |
6.2.1 Overview and Analysis |
6.2.2 Latvia Adeno Associated Virus Vector Manufacturing Market Revenues & Volume, By Hematological Diseases, 2021- 2031F |
6.2.3 Latvia Adeno Associated Virus Vector Manufacturing Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.2.4 Latvia Adeno Associated Virus Vector Manufacturing Market Revenues & Volume, By Genetic Disorders, 2021- 2031F |
6.2.5 Latvia Adeno Associated Virus Vector Manufacturing Market Revenues & Volume, By Neurological Disorders, 2021- 2031F |
6.2.6 Latvia Adeno Associated Virus Vector Manufacturing Market Revenues & Volume, By Ophthalmic Disorders, 2021- 2031F |
6.3 Latvia Adeno Associated Virus Vector Manufacturing Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Latvia Adeno Associated Virus Vector Manufacturing Market Revenues & Volume, By Cell Therapy, 2021- 2031F |
6.3.3 Latvia Adeno Associated Virus Vector Manufacturing Market Revenues & Volume, By Gene Therapy, 2021- 2031F |
6.3.4 Latvia Adeno Associated Virus Vector Manufacturing Market Revenues & Volume, By Vaccine, 2021- 2031F |
6.4 Latvia Adeno Associated Virus Vector Manufacturing Market, By Method Scope |
6.4.1 Overview and Analysis |
6.4.2 Latvia Adeno Associated Virus Vector Manufacturing Market Revenues & Volume, By In Vitro, 2021- 2031F |
6.4.3 Latvia Adeno Associated Virus Vector Manufacturing Market Revenues & Volume, By In Vivo, 2021- 2031F |
7 Latvia Adeno Associated Virus Vector Manufacturing Market Import-Export Trade Statistics |
7.1 Latvia Adeno Associated Virus Vector Manufacturing Market Export to Major Countries |
7.2 Latvia Adeno Associated Virus Vector Manufacturing Market Imports from Major Countries |
8 Latvia Adeno Associated Virus Vector Manufacturing Market Key Performance Indicators |
9 Latvia Adeno Associated Virus Vector Manufacturing Market - Opportunity Assessment |
9.1 Latvia Adeno Associated Virus Vector Manufacturing Market Opportunity Assessment, By Scale of Operations, 2021 & 2031F |
9.2 Latvia Adeno Associated Virus Vector Manufacturing Market Opportunity Assessment, By Therapeutic Area Scope, 2021 & 2031F |
9.3 Latvia Adeno Associated Virus Vector Manufacturing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Latvia Adeno Associated Virus Vector Manufacturing Market Opportunity Assessment, By Method Scope, 2021 & 2031F |
10 Latvia Adeno Associated Virus Vector Manufacturing Market - Competitive Landscape |
10.1 Latvia Adeno Associated Virus Vector Manufacturing Market Revenue Share, By Companies, 2024 |
10.2 Latvia Adeno Associated Virus Vector Manufacturing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here